| Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 L Swadling, MO Diniz, NM Schmidt, OE Amin, A Chandran, E Shaw, ... Nature 601 (7891), 110-117, 2022 | 367 | 2022 |
| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 332 | 2022 |
| Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Science immunology 5 (54), eabf3698, 2020 | 210 | 2020 |
| Genomic investigations of unexplained acute hepatitis in children S Morfopoulou, S Buddle, OE Torres Montaguth, L Atkinson, ... Nature 617 (7961), 564-573, 2023 | 120 | 2023 |
| Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study RK Gupta, J Rosenheim, LC Bell, A Chandran, JA Guerra-Assuncao, ... The Lancet Microbe 2 (10), e508-e517, 2021 | 67 | 2021 |
| Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections A Chandran, J Rosenheim, G Nageswaran, L Swadling, G Pollara, ... Cell Reports Medicine 3 (3), 2022 | 53 | 2022 |
| Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease G Pollara, CT Turner, J Rosenheim, A Chandran, LCK Bell, A Khan, ... Science translational medicine 13 (592), eabg7673, 2021 | 42 | 2021 |
| HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19 S Astbury, CJ Reynolds, DK Butler, DC Muñoz‐Sandoval, KM Lin, ... Immunology 166 (1), 68-77, 2022 | 31 | 2022 |
| COVIDsortium investigators; COVIDsortium immune correlates network, Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Sci. Immunol 5, 2020 | 10 | 2020 |
| Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection M Milighetti, Y Peng, C Tan, M Mark, G Nageswaran, S Byrne, T Ronel, ... Iscience 26 (6), 2023 | 8 | 2023 |
| Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response I Doykov, T Baldwin, J Spiewak, KC Gilmour, JM Gibbons, C Pade, ... Cell Reports Methods 2 (9), 2022 | 7 | 2022 |
| Healthcare workers with mild/asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... medRxiv, 2020.10. 13.20211763, 2020 | 7 | 2020 |
| SARS-CoV-2 human challenge reveals single-gene blood transcriptional biomarkers that discriminate early and late phases of acute respiratory viral infections J Rosenheim, RK Gupta, C Thakker, T Mann, LCK Bell, CM Broderick, ... medRxiv, 2023.06. 01.23290819, 2023 | 5 | 2023 |
| Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection RK Gupta, J Rosenheim, LC Bell, A Chandran, JA Guerra-Assuncao, ... medRxiv, 2021.01. 18.21250044, 2021 | 5 | 2021 |
| Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses A Chandran, J Rosenheim, G Nageswaran, L Swadling, G Pollara, ... MedRxiv, 2021.03. 30.21254540, 2021 | 4 | 2021 |
| Detection of M. tuberculosis DNA in TB contacts’ PBMC does not associate with blood RNA signatures for incipient tuberculosis J Rosenheim, M Abebe, M Belay, B Tulu, D Tayachew, M Tegegn, ... European Respiratory Journal, 2024 | 3 | 2024 |
| Detection of M. tuberculosis DNA in peripheral blood mononuclear cells of tuberculosis contacts does not associate with blood RNA signatures for incipient … J Rosenheim, M Abebe, M Belay, B Tulu, D Tayachew, M Tegegn, ... European Respiratory Journal 64 (6), 2400479, 2024 | | 2024 |
| SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections J Rosenheim, RK Gupta, C Thakker, T Mann, LCK Bell, CM Broderick, ... Nature Communications 15 (1), 10434, 2024 | | 2024 |
| Variation in beta-defensin expression in the control of Mycobacterium tuberculosis J Rosenheim UCL (University College London), 2024 | | 2024 |
| Type I interferon responses contribute to immune protection against mycobacterial infection A Szydlo-Shein, B Sanz-Magallón Duque de Estrada, J Rosenheim, ... medRxiv, 2024.06. 26.24309490, 2024 | | 2024 |
